{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:35:27Z","timestamp":1790652927935,"version":"4.1.0"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Medication-related events (MREs) are a frequent cause of emergency department (ED) visits and patient harm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the efficacy of a pharmacist-led transition of care program in reducing ED visits related to the same MRE at 6 months compared with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective, open-label, parallel-group randomized clinical trial was conducted from November 2018 to July 2021 at the ED of Montpellier University Hospital, Montpellier, France, with a 6-month follow-up period. Adult patients with an MRE detected at ED admission were included. MREs included adverse drug events with or without misuse and medication nonadherence with unfavorable clinical evolution. End points were assessed blindly from the randomization arm. Data were analyzed from January 2022 to March 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants were randomized to a pharmacist-led transition of care program or usual care. Usual care included the ED pharmacist carrying out a medication history. In the transition of care group, ED pharmacists additionally made a postdischarge telephone call to the general practitioner (GP) and community pharmacist, along with a letter, notifying them about MRE type, suspected medication, and management recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the proportion of patients with an ED visit for the same MRE at 6\u2009months (same symptom and medication involved). Secondary outcomes included proportions of all-cause and MRE-related ED visits, hospitalizations, deaths, and medical office visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 330 patients analyzed, 187 (56.7%) were female, the median (IQR) age was 71 (50-83) years, and the median (IQR) home medications count was 6 (3-10). A total of 167 patients were randomized to the transition of care group and 163 to the control group. At 6 months, fewer participants in the transition of care group had ED visits related to the same MRE (5 [3.0%] vs 36 [22.1%]; risk difference [RD], \u221219.1 percentage points; 95% CI, \u221226.0 to \u221212.2;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), all-cause ED visits (35 [21.0%] vs 57 [35.0%]; RD, \u221214.0 percentage points; 95% CI, \u221223.6 to \u22124.4), hospitalization related to the same MRE (3 [1.8%] vs 29 [17.8%]; RD, \u221216.0 percentage points; 95% CI, \u221222.2 to \u22129.8), and more GP office visits (88 of 158 [55.7%] vs 26 of 146 [17.8%]; RD, 37.9 percentage points; 95% CI, 28.0 to 47.8) and specialist office visits (67 of 158 [42.4%] vs 35 of 146 [24.0%]; RD, 18.4 percentage points; 95% CI, 8.1 to 28.8) related to the same MRE. All-cause hospitalization and death were similar between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, a pharmacist-led transitional care intervention in the ED among patients with MRE significantly reduced ED visits and hospitalizations for the same MRE. If replicated in subsequent trials, this strategy offers a novel approach for reducing drug-related harms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03725046\">NCT03725046<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2025.0640","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:31:02Z","timestamp":1745839862000},"page":"669","source":"Crossref","is-referenced-by-count":15,"title":["Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention"],"prefix":"10.1001","volume":"185","author":[{"given":"Maxime","family":"Villiet","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Laureau","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France"},{"name":"Emergency Medicine Department, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Perier","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pinzani","sequence":"additional","affiliation":[{"name":"Medical Pharmacology and Toxicology Department, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Giraud","sequence":"additional","affiliation":[{"name":"Economic Evaluation Unit, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lohan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France"},{"name":"PhyMedExp, University of Montpellier, CNRS, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bobbia","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, CHU Montpellier, University of Montpellier, Montpellier, France"},{"name":"Department of Emergency Medicine, UR UM 103 (IMAGINE), Montpellier University, Montpellier University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Mercier","sequence":"additional","affiliation":[{"name":"Health Data Science Unit, CHU Montpellier, University of Montpellier, Montpellier, France"},{"name":"IDESP, INSERM, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Jaussent","sequence":"additional","affiliation":[{"name":"Clinical Research and Epidemiology Unit, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Macioce","sequence":"additional","affiliation":[{"name":"Clinical Research and Epidemiology Unit, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Sebbane","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Faucani\u00e9","sequence":"additional","affiliation":[{"name":"Clinical Research and Epidemiology Unit, CHU Montpellier, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Breuker","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France"},{"name":"PhyMedExp, University of Montpellier, CNRS, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ioi250014r2","doi-asserted-by":"publisher","first-page":"E446","DOI":"10.9778\/cmajo.20180190","article-title":"Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia, Canada.","volume":"7","author":"Hohl","year":"2019","journal-title":"CMAJ Open"},{"issue":"16","key":"ioi250014r3","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care.","volume":"348","author":"Gandhi","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"ioi250014r4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.annemergmed.2009.10.008","article-title":"Do emergency physicians attribute drug-related emergency department visits to medication-related problems?","volume":"55","author":"Hohl","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"6","key":"ioi250014r5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1067\/mem.2001.119456","article-title":"Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department.","volume":"38","author":"Hohl","year":"2001","journal-title":"Ann Emerg Med"},{"issue":"3","key":"ioi250014r6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1197\/j.aem.2004.08.056","article-title":"Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department.","volume":"12","author":"Hohl","year":"2005","journal-title":"Acad Emerg Med"},{"issue":"12","key":"ioi250014r7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1503\/cmaj.071594","article-title":"Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.","volume":"178","author":"Zed","year":"2008","journal-title":"CMAJ"},{"issue":"12","key":"ioi250014r8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00228-017-2330-3","article-title":"The prevalence of medication-related adverse events in inpatients\u2014a systematic review and meta-analysis.","volume":"73","author":"Laatikainen","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"ioi250014r9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40264-020-00918-3","article-title":"Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: a systematic review.","volume":"43","author":"Alqenae","year":"2020","journal-title":"Drug Saf"},{"issue":"1","key":"ioi250014r10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events. implications for prevention.","volume":"274","author":"Bates","year":"1995","journal-title":"JAMA"},{"issue":"4","key":"ioi250014r11","first-page":"176","article-title":"Prevalence of adverse drug events in emergency departments. FARM-URG multi-center project.","volume":"45","author":"Ruiz-Ramos","year":"2021","journal-title":"Farm Hosp"},{"issue":"10","key":"ioi250014r14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40266-017-0490-6","article-title":"Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital.","volume":"34","author":"Parameswaran Nair","year":"2017","journal-title":"Drugs Aging"},{"issue":"9","key":"ioi250014r15","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.3390\/ijerph19095585","article-title":"Persistence of adverse drug reaction-related hospitalization risk following discharge.","volume":"19","author":"Schmid","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"ioi250014r16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2125.2006.02839.x","article-title":"Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.","volume":"63","author":"Zhang","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"ioi250014r17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00228-016-2022-4","article-title":"Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.","volume":"72","author":"Hauviller","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"ioi250014r18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jhm.228","article-title":"Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.","volume":"2","author":"Kripalani","year":"2007","journal-title":"J Hosp Med"},{"issue":"12","key":"ioi250014r19","first-page":"886","article-title":"Communication at the interface between hospitals and primary care - a general practice audit of hospital discharge summaries.","volume":"42","author":"Belleli","year":"2013","journal-title":"Aust Fam Physician"},{"issue":"8","key":"ioi250014r20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s11606-023-08541-5","article-title":"Primary care physicians\u2019 perspectives on high-quality discharge summaries.","volume":"39","author":"Chatterton","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"1","key":"ioi250014r21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u207936.w3197","article-title":"Mind the gap: improving discharge communication between secondary and primary care.","volume":"4","author":"Cresswell","year":"2015","journal-title":"BMJ Qual Improv Rep"},{"issue":"1","key":"ioi250014r22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s12913-023-10221-3","article-title":"Hospital doctors\u2019 and general practitioners\u2019 perspectives of outpatient discharge processes in Australia: an interpretive approach.","volume":"23","author":"Kruys","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"ioi250014r23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1001\/jamainternmed.2020.9282","article-title":"Adverse drug events after hospitalization-are we missing the mark?","volume":"181","author":"Bongiovanni","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"8","key":"ioi250014r24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010791.pub2","article-title":"Impact of medication reconciliation for improving transitions of care.","author":"Redmond","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"ioi250014r25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/ajhp\/zxaa090","article-title":"Pharmacist-led program to improve transitions from acute care to skilled nursing facility care.","volume":"77","author":"Achilleos","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"ioi250014r26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ajhp\/zxaa012","article-title":"Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes.","volume":"77","author":"Bae-Shaaw","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"ioi250014r27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ajhp\/zxaa081","article-title":"Effects of pharmacy interventions at transitions of care on patient outcomes.","volume":"77","author":"Fosnight","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"ioi250014r28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/ajhp\/zxaa071","article-title":"Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system.","volume":"77","author":"Miller","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"ioi250014r29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/ajhp\/zxaa091","article-title":"Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions.","volume":"77","author":"Snyder","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"ioi250014r30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11606-016-3596-3","article-title":"Effect of pharmacist counseling intervention on health care utilization following hospital discharge: a randomized control trial.","volume":"31","author":"Bell","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"3","key":"ioi250014r31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jamainternmed.2017.8274","article-title":"Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial.","volume":"178","author":"Ravn-Nielsen","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"5","key":"ioi250014r32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1001\/jamainternmed.2020.9285","article-title":"Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial.","volume":"181","author":"Gurwitz","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"9","key":"ioi250014r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.10756","article-title":"Effect of an electronic medication reconciliation intervention on adverse drug events: a cluster randomized trial.","volume":"2","author":"Tamblyn","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"ioi250014r34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","article-title":"The MedSafer study\u2014electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial.","volume":"182","author":"McDonald","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi250014r35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s13063-021-05501-4","article-title":"Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial.","volume":"22","author":"Breuker","year":"2021","journal-title":"Trials"},{"issue":"5","key":"ioi250014r36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups.","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ioi250014r37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions.","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"},{"issue":"3","key":"ioi250014r38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"ioi250014r39","doi-asserted-by":"publisher","first-page":"a2752","DOI":"10.1136\/bmj.a2752","article-title":"Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study.","volume":"338","author":"Zhang","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"ioi250014r40","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamainternmed.2017.1435","article-title":"Missed opportunities for deprescription: a teachable moment.","volume":"177","author":"Raslan","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"8","key":"ioi250014r41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.297.8.831","article-title":"Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care.","volume":"297","author":"Kripalani","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"ioi250014r42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.annemergmed.2011.10.023","article-title":"Effective discharge communication in the emergency department.","volume":"60","author":"Samuels-Kalow","year":"2012","journal-title":"Ann Emerg Med"},{"issue":"3","key":"ioi250014r43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamainternmed.2023.7628","article-title":"Care fragmentation, care continuity, and care coordination\u2014how they differ and why it matters.","volume":"184","author":"Kern","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"21","key":"ioi250014r44","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans.","volume":"365","author":"Budnitz","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"ioi250014r45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/bmjqs-2021-014185","article-title":"Medication-related medical emergency team activations: a case review study of frequency and preventability.","volume":"32","author":"Levkovich","year":"2023","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"ioi250014r46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7326\/0003-4819-155-2-201107190-00005","article-title":"Low health literacy and health outcomes: an updated systematic review.","volume":"155","author":"Berkman","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10","key":"ioi250014r47","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/acem.12476","article-title":"Is low health literacy associated with increased emergency department utilization and recidivism?","volume":"21","author":"Griffey","year":"2014","journal-title":"Acad Emerg Med"},{"issue":"6","key":"ioi250014r48","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1553-2712.2012.01379.x","article-title":"Clinical decision rules to improve the detection of adverse drug events in emergency department patients.","volume":"19","author":"Hohl","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"7","key":"ioi250014r49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00228-009-0641-8","article-title":"Regional surveillance of emergency-department visits for outpatient adverse drug events.","volume":"65","author":"Capuano","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"ioi250014r50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.annemergmed.2011.01.003","article-title":"Outcomes of emergency department patients presenting with adverse drug events.","volume":"58","author":"Hohl","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"12","key":"ioi250014r51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s002280050582","article-title":"Suspected adverse drug events requiring emergency department visits or hospital admissions.","volume":"54","author":"Raschetti","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"ioi250014r52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/emermed-2013-202531","article-title":"Classifying emergency 30-day readmissions in England using routine hospital data 2004-2010: what is the scope for reduction?","volume":"32","author":"Blunt","year":"2015","journal-title":"Emerg Med J"},{"issue":"12","key":"ioi250014r53","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ajhp\/zxaa080","article-title":"Implementation of a pharmacist-led transitional care clinic.","volume":"77","author":"Layman","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"ioi250014r54","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jama.2019.11982","article-title":"Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial.","volume":"322","author":"Aboumatar","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"ioi250014r55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/acem.14661","article-title":"Patient experiences of a care transition intervention for veterans to reduce emergency department visits.","volume":"30","author":"Seidenfeld","year":"2023","journal-title":"Acad Emerg Med"},{"issue":"11","key":"ioi250014r56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009985.pub2","article-title":"Reducing medication errors for adults in hospital settings.","author":"Ciapponi","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ioi250014r57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11606-008-0882-8","article-title":"Association of communication between hospital-based physicians and primary care providers with patient outcomes.","volume":"24","author":"Bell","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"1","key":"ioi250014r58","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1186\/s12913-021-07398-w","article-title":"Direct phone communication to primary care physician to plan discharge from hospital: feasibility and benefits.","volume":"21","author":"Enzinger","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"ioi250014r59","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1002\/jhm.474","article-title":"Communication and information deficits in patients discharged to rehabilitation facilities: an evaluation of five acute care hospitals.","volume":"4","author":"Gandara","year":"2009","journal-title":"J Hosp Med"},{"issue":"1","key":"ioi250014r60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12245-018-0203-x","article-title":"Assessing utility and completeness of information transmission during emergency department transfers.","volume":"11","author":"Lewis","year":"2018","journal-title":"Int J Emerg Med"},{"issue":"1","key":"ioi250014r61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12913-019-3989-1","article-title":"A systematic literature review and narrative synthesis on the risks of medical discharge letters for patients\u2019 safety.","volume":"19","author":"Schwarz","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"ioi250014r1","volume-title":"Dictionnaire Fran\u00e7ais de L\u2019erreur M\u00e9dicamenteuse","author":"Schmitt","year":"2006"},{"key":"ioi250014r12","unstructured":"World Health Organization. Medication Without Harm: WHO Global Patient Safety Challenge. Accessed December 10, 2024. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIS-SDS-2017.6"},{"key":"ioi250014r13","unstructured":"US Department of Health and Human Services Office of Disease prevention and Health Promotion. National action plan for adverse drug event prevention. Accessed December 10, 2024. https:\/\/odphp.health.gov\/sites\/default\/files\/2019-09\/ADE-Action-Plan-508c.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2833309\/jamainternal_villiet_2025_oi_250014_1748025364.60214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:01:20Z","timestamp":1748862080000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2833309"}},"subtitle":["The URGEIM Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2025.0640","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}